Weiya Xia

机构：The University of Texas MD Anderson Cancer Center, China Medical University

发表论文 286 篇 · 总被引 31559 次 · h-index 76

代表论文

Targeting ALK averts ribonuclease 1-induced immunosuppression and enhances antitumor immunity in hepatocellular carcinoma (2024 · Nature Communications · 被引 23)
Targeting a chemo-induced adaptive signaling circuit confers therapeutic vulnerabilities in pancreatic cancer (2024 · Cell Discovery · 被引 10)
MTAP deficiency confers resistance to cytosolic nucleic acid sensing and STING agonists (2025 · Science · 被引 9)
FGFR3-induced Y158 PARP1 phosphorylation promotes PARP inhibitor resistance via BRG1/MRE11-mediated DNA repair in breast cancer models (2025 · Journal of Clinical Investigation · 被引 5)
WITHDRAWN: Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function (2025 · Molecular Cell · 被引 1)
Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function (2025 · Molecular Cell · 被引 1)